(Q54335439)

28 May 2018

title

Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer. (English)

1 reference

28 May 2018

0 references

1 reference

1 reference

Xin-Juan Fan

1

1 reference

28 May 2018

Xiang-Bo Wan

2

1 reference

28 May 2018

Xin-Hui Fu

3

1 reference

28 May 2018

Pei-Huang Wu

4

1 reference

28 May 2018

Dian-Ke Chen

5

1 reference

28 May 2018

Pu-Ning Wang

6

1 reference

28 May 2018

Li Jiang

7

1 reference

28 May 2018

Dao-Hai Wang

8

1 reference

28 May 2018

Zhi-Ting Chen

9

1 reference

28 May 2018

Yan Huang

10

1 reference

28 May 2018

Jian-Ping Wang

11

1 reference

28 May 2018

Lei Wang

12

1 reference

28 May 2018

publication date

24 July 2014

1 reference

28 May 2018

published in

Tumor Biology

1 reference

28 May 2018

volume

35

1 reference

28 May 2018

issue

10

1 reference

28 May 2018

page(s)

10487-10495

1 reference

28 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Impact of EGFR expression on colorectal cancer patient prognosis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Genetic prognostic and predictive markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

KRAS mutational status as a predictor of epidermal growth factor receptor inhibitor efficacy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Mitogen-activated protein kinase cascades and regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Extracellular signals and reversible protein phosphorylation: what to Mek of it all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Molecular prognostic prediction for locally advanced nasopharyngeal carcinoma by support vector machine integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Irinotecan induces senescence and apoptosis in colonic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Randomised trials of HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2320-3

Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25056534

12 December 2020

inferred from PubMed ID database lookup

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25056534

12 December 2020

inferred from PubMed ID database lookup

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25056534

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S13277-014-2320-3

1 reference

28 May 2018

release_fx7fvxotxjccbpbgsqgnb7baim

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fx7fvxotxjccbpbgsqgnb7baim

24 November 2022

mapped directly with Wikidata item

1 reference

28 May 2018